Skip to main content
Clinical Trials/NCT03066583
NCT03066583
Completed
Phase 2

Prospective, Randomised, Double Blinded Trial Comparing Effectiveness of Platelet Rich Plasma or Placebo in a Primary Meniscal Tear Treatment

Centre of Postgraduate Medical Education1 site in 1 country72 target enrollmentJanuary 2016
ConditionsMeniscus Lesion

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Meniscus Lesion
Sponsor
Centre of Postgraduate Medical Education
Enrollment
72
Locations
1
Primary Endpoint
Assessment of meniscal healing by MR scanning
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study will compare meniscal healing augmented or without augmentation with platelet rich plasma in primary meniscal tear treatment (prolotherapy). The assessments will include validated, disease specific, patient oriented outcome measures. Results of this study will help ascertain whether platelet rich plasma may improve meniscal healing rates.

Detailed Description

The role of meniscal in the knee integrity is pivotal and lack or partial role of the meniscus increases rate of joint degeneration. Partial meniscal removal is the most popular procedure and meniscal repair remain in minority of arthroscopic surgeries. As criteria of inclusion to meniscal repair are very rough, still success rates of meniscal repair remain in the 60-80% range for isolated repairs. This rate is greater when performed with ACL reconstruction. The investigators believe that augmentation with platelet rich plasma as prolotherapy ill induce healing without the need for arthroscopy.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
June 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre of Postgraduate Medical Education
Responsible Party
Principal Investigator
Principal Investigator

Rafał Kamiński

Deputy Chair of Division

Centre of Postgraduate Medical Education

Eligibility Criteria

Inclusion Criteria

  • Complete horizontal 10 mm in length
  • Tear located in the vascular/avascular portion of the meniscus (chronic horizontal tear on MR)
  • Single tear of the medial and/or lateral meniscus
  • Skeletally mature patients 18-70 years of age

Exclusion Criteria

  • discoid meniscus
  • arthritic changes (Kellgren Lawrence scale \>2) or axial leg deformity (valgus \> 6 deg)
  • inflammatory diseases (i.e. rheumatoid arthritis)
  • concominant chondral defects (\> 2 ICRS)

Outcomes

Primary Outcomes

Assessment of meniscal healing by MR scanning

Time Frame: by 1 year

The primary outcome measures will be assessment of meniscal healing integrity by MR scanning

Secondary Outcomes

  • Visual Analog Scale(12 weeks, 6months, 1year post procedure)
  • Knee injury and Osteoarthritis Outcome Score scale(12 weeks, 6months, 1year post procedure)
  • International Knee Documentation Committee - Subjective Knee Evaluation Form(12 weeks, 6months, 1year post procedure)

Study Sites (1)

Loading locations...

Similar Trials